Author Affiliations: Department of Surgery (Dr Pronovost), and Department of Anesthesiology and Critical Care Medicine, Quality and Safety Research Group, Johns Hopkins University School of Medicine, Baltimore, Maryland (Drs Pronovost and Goeschel); Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health (Drs Pronovost and Goeschel); and Johns Hopkins University School of Nursing (Drs Pronovost and Goeschel).
Biomedical science has made amazing life-saving discoveries. The science of “omics” offers hope for further improvements in preventing, prognosticating, and personalizing care. Each year, researchers publish approximately 18 000 active clinical trials,1 yet a gap remains between the development and publication of this new knowledge and better patient outcomes. While clinical translational science awards strive to improve population health, their predominant focus has been on translating basic research findings to humans. Although this Commentary focuses on preventable harm within the health care system, the principles discussed likely apply to optimizing population health using a broader set of public health interventions.
Pronovost PJ, Goeschel CA. Time to Take Health Delivery Research Seriously. JAMA. 2011;306(3):310–311. doi:10.1001/jama.2011.1015
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.